Selective IgA deficiency is the most common primary immunodeficiency, yet most people who have it never know. The condition is defined by very low or absent levels of immunoglobulin A in the blood while other antibody types remain normal. What makes it unusual among immune disorders is the wide gap between how many people carry the diagnosis and how many actually get sick from it. Some live entirely symptom-free; others deal with recurring infections, autoimmune diseases, or gut problems that can take years to trace back to their missing antibody.
What IgA Does and Why Losing It Matters
IgA is the dominant antibody at mucosal surfaces, the wet linings of your respiratory tract, gut, urinary tract, and eyes. Your body produces more IgA than all other antibody classes combined, and most of it is secreted directly onto those surfaces rather than circulating in the bloodstream. There, secretory IgA acts as a first-pass filter. It coats bacteria and viruses before they can attach to the lining cells, a process sometimes called immune exclusion. But recent research shows IgA does more than passively block invaders. It also plays a role in specific immune responses and in regulating how the immune system interacts with the trillions of harmless bacteria living in the gut.
1PubMed Central. The Effects of Secretory IgA in the Mucosal Immune SystemThis creates a diagnostic quirk. The standard blood test measures serum IgA, the fraction circulating in the bloodstream. But the IgA that matters most for day-to-day protection is the secretory form coating your mucosal surfaces, and that is not routinely measured. Some people who test as IgA-deficient in blood may still have partial mucosal protection, while others lack both. A 2024 study found that the symptoms and immune disruption in IgA-deficient individuals were concentrated in those who also lacked fecal IgA, not just serum IgA.
2PubMed Central. IgA deficiency destabilizes homeostasis toward intestinal microbes and increases systemic immune dysregulationWhy Most People With IgA Deficiency Feel Fine
The immune system has backup plans. When IgA is absent, the body ramps up production of other antibodies, especially IgM, to partially fill the gap. Research has shown that people with selective IgA deficiency have significantly increased levels of secretory IgM and IgG antibodies at mucosal surfaces. In the mouth, this compensation appears effective enough that oral microbiota composition in IgA-deficient individuals looks essentially normal.
3PubMed. Compensatory IgM to the Rescue: Patients with Selective IgA Deficiency Have Increased Natural IgM Antibodies to MAA-LDL and No Changes in Oral MicrobiotaThe gut is a different story. Even though compensatory IgM reaches the intestinal lumen, it does not target bacteria with the same precision that IgA does. IgA normally coats a specific subset of gut microbes with high selectivity, while compensatory IgM binds more broadly and less efficiently. The result is that IgA-deficient people tend to show shifts in their gut bacterial communities: lower overall diversity, expansion of certain potentially harmful species, and depletion of some beneficial ones.
4PubMed Central. IgA-deficient humans exhibit gut microbiota dysbiosis despite secretion of compensatory IgMSo the compensation works, but imperfectly. Whether someone with IgA deficiency stays healthy or develops symptoms likely depends on how well IgM fills in, how their gut microbiome adapts, and whether they carry genetic risk factors for autoimmune diseases on top of the deficiency.
The Gut Microbiome Connection
The interplay between IgA and gut bacteria has become one of the more interesting areas of research. Multiple studies have confirmed that IgA plays a nonredundant role in maintaining the microbial ecosystem of the intestine. Without it, certain bacteria that normally stay in the mouth start colonizing the gut, pathogenic species expand, and some of the commensal bacteria that help regulate inflammation decline.
5PubMed. Microbial ecology perturbation in human IgA deficiencyThese shifts are not just academic observations. The microbiome disruption appears to have downstream immune consequences. When certain gut bacteria translocate across the intestinal barrier in IgA-deficient individuals, the systemic immune system responds with increased inflammatory signals, elevated activity of certain T cell populations, and higher levels of antibodies directed against fecal bacteria. This chain of events may help explain why IgA deficiency is linked to so many autoimmune conditions: the constant low-grade immune activation from a poorly controlled microbiome could prime the body to start attacking its own tissues.
6PubMed Central. IgA deficiency destabilizes homeostasis toward intestinal microbes and increases systemic immune dysregulationInfections That Keep Coming Back
When IgA deficiency does cause symptoms, the pattern is often recognizable: recurrent infections of the sinuses, lungs, ears, and gut. Chronic sinus infections are particularly common, and there is a high prevalence of chronic rhinosinusitis among people with selective IgA deficiency.
7PubMed Central. Antibody deficiency in chronic rhinosinusitis: epidemiology and burden of illnessGastrointestinal infections also appear more frequently, with a particular vulnerability to the parasite Giardia lamblia. Upper respiratory infections with both bacteria and viruses tend to recur, and urinary tract infections are also reported more often. The pattern makes anatomical sense: the areas most affected are exactly the mucosal surfaces where IgA would normally be providing first-line defense.
8PubMed Central. The clinical implications of selective IgA deficiencyThe severity varies enormously from person to person. Some people get a few extra colds per year. Others end up on rotating courses of antibiotics for sinusitis that never fully clears. When infections are frequent and severe, it is worth investigating whether the IgA deficiency exists alongside another immune gap, such as low levels of certain IgG subtypes, because that combination tends to produce a more significant clinical picture.
The Autoimmune Overlap
IgA deficiency comes bundled with an elevated risk for a surprisingly wide range of autoimmune diseases. A large review identified strong evidence linking IgA deficiency to lupus, both overactive and underactive thyroid disease, type 1 diabetes, Crohn’s disease, ulcerative colitis, rheumatoid arthritis, juvenile arthritis, ankylosing spondylitis, and vitiligo. Weaker but still notable associations exist with celiac disease, autoimmune hepatitis, and certain blood-related autoimmune conditions.
9PubMed. The Epidemiology and Clinical Manifestations of Autoimmunity in Selective IgA DeficiencyThe celiac disease connection deserves special attention because it is bidirectional and clinically consequential. IgA deficiency is roughly ten to fifteen times more common in people with celiac disease than in the general population.
10PubMed Central. Celiac disease and immunoglobulin a deficiency: how effective are the serological methods of diagnosis? This matters for diagnosis because the standard screening blood test for celiac disease measures IgA-based antibodies. If you are IgA-deficient, those tests will come back falsely negative even if you have celiac disease. Doctors need to know about the IgA deficiency to order the correct alternative test, one based on IgG antibodies instead. People with IgA deficiency who have unexplained digestive symptoms, weight loss, or iron deficiency should be screened for celiac disease with IgG-based testing.
Part of the genetic explanation for this overlap involves the HLA region, a stretch of DNA central to immune function. Certain HLA variants are overrepresented in both IgA deficiency and celiac disease. In particular, two of the three HLA gene combinations most commonly found in IgA-deficient individuals include an allele that is also a key predisposing factor for celiac disease.
11PubMed Central. The Role of HLA in the Association between IgA Deficiency and Celiac DiseaseAllergies and Atopic Disease
Alongside the autoimmune associations, IgA deficiency has long been suspected of raising the risk of allergic conditions. Eczema, allergic rhinitis, and asthma all appear more frequently in people with the deficiency than in the general population.
12PubMed Central. The Epidemiology and Clinical Presentations of Atopic Diseases in Selective IgA Deficiency The likely explanation ties back to mucosal immunity. Without IgA preventing allergens and microbial products from penetrating mucosal barriers, the immune system encounters more foreign material than it should, and some of those encounters lead to allergic sensitization rather than tolerance. The altered gut microbiome in IgA deficiency may compound the problem, since the microbial communities that normally help train the immune system toward tolerance are disrupted.
Genetics and the Spectrum With CVID
IgA deficiency is not caused by a single gene. The genetics are complex, with the strongest associations mapped to the HLA region on chromosome 6. High-density genetic mapping has identified multiple independent risk signals within this region. The primary signal corresponds to a specific HLA class II allele, with an odds ratio of about 2.8, while secondary signals from other alleles in the region push risk even higher or, in one case, are strongly protective.
13PLOS Genetics. High-Density SNP Mapping of the HLA Region Identifies Multiple Independent Susceptibility Loci Associated with Selective IgA DeficiencyAn important clinical reality is that IgA deficiency and common variable immunodeficiency, a more severe antibody deficiency, appear to sit on the same spectrum. The two conditions share genetic risk factors, occur together in the same families, and involve similar underlying problems with B cell development. In a study of Swedish families, both IgA deficiency and CVID appeared in twelve out of thirty-four families, with CVID more common in the parents’ generation and IgA deficiency in their children. This proportion was far higher than chance would predict, strongly suggesting a shared genetic basis with variable expression.
14Clinical Immunology and Immunopathology. Family and Linkage Study of Selective IgA Deficiency and Common Variable ImmunodeficiencyIn a small number of cases, IgA deficiency progresses to CVID over time. This is not common, but it means that someone diagnosed with IgA deficiency who starts developing more frequent or severe infections, or whose other immunoglobulin levels begin dropping, should have periodic monitoring.
15PubMed. Progression of selective IgA deficiency to common variable immunodeficiency Mutations in a gene involved in B cell survival (known as TACI) have been identified as disease-modifying factors in both conditions, reinforcing the idea that they represent different points on a single continuum of immune dysregulation.
16PubMed Central. Selective IgA deficiencyThe Transfusion Question
One of the more anxiety-inducing aspects of an IgA deficiency diagnosis is the possibility of a severe allergic reaction to blood transfusions. The concern is that some IgA-deficient people develop anti-IgA antibodies, and when they receive blood products containing IgA, those antibodies can trigger anaphylaxis. This is a real phenomenon, but the risk is frequently overstated.
Anti-IgA antibodies have been detected in a substantial fraction of IgA-deficient individuals, but their presence does not reliably predict who will actually have a reaction. In one study, the standard test detected anti-IgA in about three-quarters of IgA-deficient patients who had previously experienced an anaphylactic transfusion reaction, but also in roughly a fifth of asymptomatic IgA-deficient blood donors who had never had any problem.
17Blood. Hemagglutination assays for the diagnosis and prevention of IgA anaphylactic transfusion reactions The test lacks the specificity to separate those truly at risk from those who happen to carry the antibody harmlessly. The practical consequence is that anaphylactic transfusion reactions due to IgA deficiency are probably overdiagnosed, and the number of people told they need special IgA-depleted blood products is larger than the number who genuinely require them.
18PubMed. IgA anaphylactic transfusion reactionsThat said, if you know you are IgA-deficient, it is reasonable to carry that information on a medical alert card. In an emergency, doctors can take extra precautions such as using washed red blood cells or IgA-depleted products. The risk of a severe reaction per transfusion is low, but when it happens, it can be life-threatening.
Diagnosis at Different Ages
IgA deficiency should not be diagnosed in very young children. The immune system matures gradually, and IgA levels are normally low in infancy and rise over the first several years of life. A condition called transient hypogammaglobulinemia of infancy involves delayed maturation of IgG and IgA that resolves on its own, typically by age four.
19ScienceDirect. Transient hypogammaglobulinemia of infancy Diagnosing permanent IgA deficiency before age four is unreliable, because you cannot distinguish a child whose IgA will eventually rise from one whose levels will stay low. Most immunologists wait until at least age four, and many prefer to confirm with repeat testing before labeling the deficiency as permanent.
At the other end of life, IgA deficiency that was previously asymptomatic can become more clinically significant as the immune system ages and other defense mechanisms weaken. This is also the period when the risk of autoimmune disease and certain cancers is higher in the general population, and IgA deficiency may compound those risks.
Cancer Risk
The relationship between IgA deficiency and cancer has been investigated in several studies, with results that are suggestive but not dramatic. A large population-based matched study found that IgA-deficient individuals had about a 30 percent higher overall cancer rate compared to controls, with the clearest signal for gastrointestinal cancers, where the risk was roughly 60 percent higher.
20PubMed. IgA deficiency and risk of cancer: a population-based matched cohort study An earlier combined Danish-Swedish study found elevated point estimates for stomach cancer and lymphoma in IgA-deficient patients, but the numbers were too small to reach statistical certainty.
21PubMed Central. Cancer risk among patients with IgA deficiency or common variable immunodeficiency and their relatives: a combined Danish and Swedish studyThe gastrointestinal cancer link is biologically plausible. IgA is the dominant immune guardian of the gut lining, so its absence could allow chronic inflammation and bacterial translocation that, over decades, raise the odds of malignant transformation. This is not a reason for alarm on its own, but it is another reason for IgA-deficient individuals to take persistent gastrointestinal symptoms seriously and pursue appropriate screening.
Management Without a Cure
There is no way to replace IgA specifically. Unlike other immunoglobulin deficiencies where intravenous or subcutaneous immunoglobulin therapy is standard treatment, commercial immunoglobulin products contain almost exclusively IgG, with very little IgA. That means immunoglobulin replacement does not fix the core problem in selective IgA deficiency.
22PubMed. Selective IgA Deficiency: Epidemiology, Pathogenesis, Clinical Phenotype, Diagnosis, Prognosis and ManagementFor people whose IgA deficiency coexists with IgG subclass deficiency or specific antibody deficiency, immunoglobulin therapy can help by boosting the IgG component. But this requires careful management, because some IgA-deficient patients carry anti-IgA antibodies that could cause reactions to infused products. Subcutaneous immunoglobulin, delivered slowly under the skin rather than directly into the bloodstream, appears to be better tolerated in many of these patients.
23PubMed Central. Association of anti-IgA antibodies with adverse reactions to gamma globulin infusionFor the majority of people with selective IgA deficiency alone, management is about treating complications as they arise. Recurring sinus infections might warrant prophylactic antibiotics. Autoimmune conditions are treated the same way they would be in anyone else. Celiac disease, if present, responds to a gluten-free diet regardless of the underlying immune deficiency. The emphasis is on awareness: knowing you are IgA-deficient lets you and your doctor watch for the patterns that tend to cluster with the condition, from celiac disease to chronic sinusitis to autoimmune thyroid disease, rather than chasing each symptom independently.
Respiratory Infections and COVID-19
The arrival of SARS-CoV-2 brought new attention to IgA deficiency. The virus enters the body primarily through the upper respiratory tract mucosa, exactly the territory where secretory IgA serves as the first line of immune defense. Recent data suggest that people with selective IgA deficiency may be at higher risk for severe COVID-19, challenging the long-standing view of the condition as uniformly mild.
24PubMed Central. Selective IgA Deficiency May Be an Underrecognized Risk Factor for Severe COVID-19This observation fits the broader immunology. IgA-based mucosal immunity is particularly important for respiratory viruses because it can neutralize pathogens before they infect cells, preventing infection at the point of entry rather than fighting it after the fact. Vaccines that generate systemic IgG responses do not necessarily produce strong mucosal IgA, which is part of why vaccinated people can still become infected (though they are protected from severe disease by their systemic immunity). For someone who lacks IgA entirely, that mucosal gap is permanent, vaccination or not. Research into mucosal vaccines that could boost secretory IgM or IgG at mucosal surfaces in IgA-deficient individuals is still in early stages.